{"id":"NCT02595398","sponsor":"Clearside Biomedical, Inc.","briefTitle":"Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis","officialTitle":"A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects With Macular Edema Associated With Non-infectious Uveitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11-17","primaryCompletion":"2018-01-18","completion":"2018-01-18","firstPosted":"2015-11-03","resultsPosted":"2021-04-28","lastUpdate":"2021-05-28"},"enrollment":160,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Uveitis","Uveitis, Posterior","Uveitis, Anterior","Uveitis, Intermediate","Panuveitis"],"interventions":[{"type":"DRUG","name":"4mg CLS-TA Suprachoriodal Injection","otherNames":["Triamcinolone Acetonide"]},{"type":"DRUG","name":"Sham Procedure","otherNames":["suprachoroidal sham"]}],"arms":[{"label":"4mg CLS-TA Suprachoriodal Injection","type":"EXPERIMENTAL"},{"label":"Sham Procedure","type":"SHAM_COMPARATOR"}],"summary":"The study is designed to evaluate the safety and efficacy of suprachoroidally administered triamcinolone acetonide, CLS-TA, in subjects with macular edema associated with non-infectious uveitis.","primaryOutcome":{"measure":"Number of Subjects Demonstrating â‰¥ 15 Letter Improvement From Baseline in Best Corrected Visual Acuity at 24 Weeks","timeFrame":"Baseline, 24 weeks","effectByArm":[{"arm":"4mg CLS-TA Suprachoriodal Injection","deltaMin":45,"sd":null},{"arm":"Sham Procedure","deltaMin":10,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":64,"countries":["United States","India","Israel"]},"refs":{"pmids":["36787524","36399237","36055922","34741564","34322164"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":96},"commonTop":["Intraocular pressure increased","Eye pain","Cataract subcapsular","Cystoid macular oedema","Intraocular pressure increased"]}}